Prosecution Insights
Last updated: August 18, 2026

Examiner: PEEBLES, KATHERINE

Tech Center 1600 • Art Units: 1614 1617 1628 1658

This examiner grants 36% of resolved cases

Performance Statistics

36.0%
Allow Rate
-24.0% vs TC avg
574
Total Applications
+49.1%
Interview Lift
1170
Avg Prosecution Days
Based on 505 resolved cases, 2023–2026

Rejection Statute Breakdown

1.9%
§101 Eligibility
8.5%
§102 Novelty
39.2%
§103 Obviousness
28.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18220852 ENCAPSULATION OF PEROXIDES FOR SKIN APPLICATIONS Final Rejection Arkema Inc.
18764882 CHLORITE USES FOR STEM CELLS Non-Final OA The Regents of the University of California
17346615 STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS Final Rejection ECOLAB USA INC.
18274964 POLYMERIC MICROPARTICLES, COMPOSITIONS, AND METHODS FOR SUSTAINED RELEASE OF AN ACTIVE AGENT SUSCEPTIBLE TO ABUSE Final Rejection Ohio State Innovation Foundation
18035174 THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF Final Rejection The General Hospital Corporation
18652169 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS Non-Final OA L'OREAL
18478091 NAIL POLISH COMPOSITION CONTAINING PIPERIDINOL COMPOUND Final Rejection L'OREAL
17862857 AGROCHEMICAL GEL COMPOSITIONS Non-Final OA MONSANTO TECHNOLOGY LLC
18250065 MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY Final Rejection Wisconsin Alumni Research Foundation
18546522 A SYNERGISTIC AGRICULTURAL COMPOSITION Final Rejection UPL Europe LTD
17797450 THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA Non-Final OA Academisch Ziekenhuis Maastricht

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month